McMillan DC (2008) An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer. Proc Nutr Soc 67:257–262
Ryan AM, Power DG, Daly L et al (2016) Cancer-associated malnutrition, cachexia and sarcopenia: the skeleton in the hospital closet 40 years later. Proc Nutr Soc 75:199–211
McMillan DC, Watson WS, O’Gorman P et al (2001) Albumin concentrations are primarily determined by the body cell mass and the systemic inflammatory response in cancer patients with weight loss. Nutr Cancer 39:210–213
Article PubMed CAS Google Scholar
Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340:448–454
Article PubMed CAS Google Scholar
Elahi MM, McMillan DC, McArdle CS et al (2004) Score based on hypoalbuminemia and elevated C-reactive protein predicts survival in patients with advanced gastrointestinal cancer. Nutr Cancer 48:171–173
Article PubMed CAS Google Scholar
Brown DJ, Milroy R, Preston T et al (2007) The relationship between an inflammation-based prognostic score (Glasgow Prognostic Score) and changes in serum biochemical variables in patients with advanced lung and gastrointestinal cancer. J Clin Pathol 60:705–708
Article PubMed CAS Google Scholar
Read JA, Choy ST, Beale PJ et al (2006) Evaluation of nutritional and inflammatory status of advanced colorectal cancer patients and its correlation with survival. Nutr Cancer 55:78–85
Article PubMed CAS Google Scholar
Kim ES, Kim SY, Koh M et al (2018) C-reactive protein binds to integrin α2 and Fcγ receptor I, leading to breast cell adhesion and breast cancer progression. Oncogene 37:28–38
Article PubMed CAS Google Scholar
Crumley AB, McMillan DC, Mckernan M et al (2006) Evaluation of an inflammation-based prognostic score in patients with inoperable gastro-oesophageal cancer. Br J Cancer 94:637–641
Article PubMed PubMed Central CAS Google Scholar
Forrest LM, McMillan DC, McArdle CS et al (2005) A prospective longitudinal study of performance status, an inflammation-based score (GPS) and survival in patients with inoperable non-small-cell lung cancer. Br J Cancer 92:1834–1836
Article PubMed PubMed Central CAS Google Scholar
Forrest LM, McMillan DC, McArdle CS et al (2004) Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer. Br J Cancer 90:1704–1706
Article PubMed PubMed Central CAS Google Scholar
Maziarz RT, Slater SS (2021) Blood and marrow transplant handbook: comprehensive guide for patient care. In: Maziarz RT (ed) Overview of hematopoietic cell transplantation and cellular therapy. Springer Nature, Switzerland 1–9
Nakamura N, Ninomiya S, Matsumoto T et al (2019) Prognostic impact of skeletal muscle assessed by computed tomography in patients with acute myeloid leukemia. Ann Hematol 98:351–359
Jung J, Lee E, Shim H et al (2021) Prediction of clinical outcomes through assessment of sarcopenia and adipopenia using computed tomography in adult patients with acute myeloid leukemia. Int J Hematol 114:44–52
Article PubMed CAS Google Scholar
Ando T, Fujisawa S, Teshigawara H et al (2019) Impact of treatment-related weight changes from diagnosis to hematopoietic stem-cell transplantation on clinical outcome of acute myeloid leukemia. Int J Hematol 109:673–683
The European Society for Clinical Nutrition and Metabolism (2019) Basics in clinical nutrition. GALEN, Prague
Scott HR, McMillan DC, Forrest LM et al (2002) The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer. Br J Cancer 87:264–267
Article PubMed PubMed Central CAS Google Scholar
McMillan DC, Elahi MM, Sattar N et al (2001) Measurement of the systemic inflammatory response predicts cancer-specific and non-cancer survival in patients with cancer. Nutr Cancer 41:64–69
Article PubMed CAS Google Scholar
Yang J, Wezeman M, Zhang M et al (2007) Human C-reactive protein binds activating Fcgamma receptors and protects myeloma tumor cells from apoptosis. Cancer Cell 12:252–265
Dupire S, Wemeau M, Debarri H et al (2012) Prognostic value of PINI index in patients with multiple myeloma. Eur J Haematol 88:306–313
Article PubMed CAS Google Scholar
Zhang Y, Chen S, Chen H et al (2023) A comprehensive analysis of Glasgow Prognostic Score (GPS)/the modified Glasgow Prognostic Score (mGPS) on immune checkpoint inhibitor efficacy among patients with advanced cancer. Cancer Med 12:38–48
Article PubMed CAS Google Scholar
Filliatre-Clement L, Broseus J, Muller M et al (2019) Serum albumin or body mass index: which prognostic factor for survival in patients with acute myeloblastic leukaemia? Hematol Oncol 37:80–84
Article PubMed CAS Google Scholar
Heppt MV, Heinzerling L, Kahler KC et al (2017) Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition. Eur J Cancer 82:56–65
Article PubMed CAS Google Scholar
Li X, Zhang Y, Zhao W et al (2015) The Glasgow Prognostic Score as a significant predictor of diffuse large B cell lymphoma treated with R-CHOP in China. Ann Hematol 94:57–63
Article PubMed CAS Google Scholar
Hao X, Wei Y, Wei X et al (2017) Glasgow Prognostic Score is superior to other inflammation-based scores in predicting survival of diffuse large B-cell lymphoma. Oncotarget 8:76740–76748
Article PubMed PubMed Central Google Scholar
Witte HM, Bonorden B, Riecke A et al (2020) The Glasgow Prognostic Score at diagnosis is a predictor of clinical outcome in patients with multiple myeloma undergoing autologous haematopoietic stem cell transplantation. Cancers (Basel) 20:12
Kyle UG, Genton L, Pichard C (2005) Hospital length of stay and nutritional status. Curr Opin Clin Nutr Metab Care 8:397–402
Petrella F, Radice D, Casiraghi M et al (2016) Glasgow Prognostic Score class 2 predicts prolonged intensive care unit stay in patients undergoing pneumonectomy. Ann Thorac Surg 102:1898–1904
Levey AS, Inker LA, Coresh L (2014) GFR estimation: from physiology to public health. Am J Kidney Dis 63:820–834
Article PubMed PubMed Central Google Scholar
Li YJ, Jiang WQ, Huang JJ et al (2013) The Glasgow Prognostic Score (GPS) as a novel and significant predictor of extranodal natural killer/T-cell lymphoma, nasal type. Am J Hematol 88:394–399
Article PubMed CAS Google Scholar
Esfahani A, Ghoreishi Z, Abedi MM et al (2014) Nutritional assessment of patients with acute leukemia during induction chemotherapy: association with hospital outcomes. Leuk Lymphoma 55:1743–1750
Article PubMed CAS Google Scholar
Jeejeebhoy KN, Keller H, Gramlich L et al (2015) Nutritional assessment: comparison of clinical assessment and objective variables for the prediction of length of hospital stay and readmission. Am J Clin Nutr 101:956–965
Article PubMed CAS Google Scholar
Beghetto MG, Luft VC, Mello ED et al (2009) Accuracy of nutritional assessment tools for predicting adverse hospital outcomes. Nutr Hosp 24:56–62
de Luis DA, Izaola O, Cuellar L et al (2006) Nutritional assessment: predictive variables at hospital admission related with length of stay. Ann Nutr Metab 50:394–398
留言 (0)